Tag Archives: patient adherence
By Guest Blogger | Published: April 1, 2013
Patient adherence to medicine is the eternal puzzle for big Pharma: what combinations of financial incentives, personalized interventions, and just good information work best to push down that stubborn 50 per cent abandonment threshold after six months of treatment? Certainly there are plenty of new programs on the market, so Pharm Exec believes it’s time [...]
By Guest Blogger | Published: March 12, 2013
by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors. Pharma is also experiencing epigenetic change. Human genes are formed from DNA, which are instructions much like a blueprint. Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
By Ben Comer | Published: November 7, 2012
Patients in search of face time with a healthcare provider are stopping into their local drugstores, where consultations are free and the wait time is shorter. Pharmacists are in a unique position, too, to move the needle on drug adherence.
By Guest Blogger | Published: April 18, 2012
Chris Evans, West Pharmaceutical Services, and Ed Geiselhart, Insight Product Development, consider the importance of drug delivery systems in facilitating patient adherence. No two patients are alike, but drug-makers may not consider how different a single patient’s perspective can be when viewed over time. A patient’s progress through disease management is a journey, and perceptions change [...]
By Jennifer Ringler | Published: May 25, 2011
With compliance rates flagging, companies have to work harder than ever to demonstrate these programs have value and represent a good ROI Pharm Exec’s sister conference organization, CBI, sponsored its 10th annual Patient Adherence Forum in April to highlight current trends in industry compliance and adherence programs — where companies reach out to help an increasingly skittish [...]